Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | DHODH | Q02127 | 6/20 | 0.44 |
| ▸ | METAP1 | P53582 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | RET | P07949 | 1/20 | 0.40 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.40 |
| ▸ | RIPK3 | Q9Y572 | 1/20 | 0.40 |
| ▸ | PKMYT1 | Q99640 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TOP1 | P11387 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20245248 | 0.95 | DHODH (0.43) | KDM4ENPC1DHODHMETAP1TSHR | |
| SCHEMBL20245040 | 0.95 | DHODH (0.45) | KDM4ENPC1DHODHMETAP1TSHR | |
| SCHEMBL20245081 | 0.95 | KDM4E (0.44) | KDM4ENPC1DHODHTSHRTDP1 | |
| SCHEMBL20245075 | 0.93 | MAPK1 (0.41) | KDM4ENPC1DHODHMETAP1TSHR | |
| SCHEMBL20249689 | 0.91 | DHODH (0.49) | KDM4ENPC1DHODHMETAP1TSHR | |
| SCHEMBL20249640 | 0.90 | DHODH (0.39) | KDM4ENPC1DHODHMETAP1TSHR | |
| SCHEMBL20249667 | 0.90 | KDM4E (0.47) | KDM4ENPC1DHODHMETAP1TSHR | |
| SCHEMBL20249611 | 0.89 | KDM4E (0.39) | KDM4ENPC1DHODHMETAP1TSHR | |
| SCHEMBL20249635 | 0.89 | PIK3CD (0.41) | KDM4ENPC1DHODHTOP1 | |
| SCHEMBL20249614 | 0.88 | KDM4E (0.38) | KDM4ENPC1DHODHMETAP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3333168-B1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2022-01-26 | — | — | EP | disclosed |
| US-10693083-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-23 | — | — | US | disclosed |
| US-20180166635-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-06-14 | — | — | US | disclosed |
| US-20180166635-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180166635-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | KDM4E 3511/4885NPC1 1192/4885DHODH 1907/4885 |
| US-10693083-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CRY2, CCNE2 | KDM4E 3511/4885NPC1 1192/4885DHODH 1907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.